COVID-19: IgG seroconversion under intensive glucocorticoid treatment in a high-risk patient with minimal change disease.
Coronavirus
Glomerulonephritis
Hyperinflammatory syndrome
Immunosuppression
Kidney disease
Journal
Wiener klinische Wochenschrift
ISSN: 1613-7671
Titre abrégé: Wien Klin Wochenschr
Pays: Austria
ID NLM: 21620870R
Informations de publication
Date de publication:
Apr 2021
Apr 2021
Historique:
received:
08
09
2020
accepted:
12
11
2020
pubmed:
9
12
2020
medline:
28
4
2021
entrez:
8
12
2020
Statut:
ppublish
Résumé
In this case report we present a rare case of a patient with multiple risk factors for severe coronavirus disease (COVID 19) in whom intensive glucocorticoid treatment due to incipient nephrotic syndrome coincided with SARS-CoV‑2 infection. Despite this high baseline risk profile and the use of glucocorticoids the patient developed only mild disease including IgG SARS-CoV‑2 seroconversion.
Identifiants
pubmed: 33289854
doi: 10.1007/s00508-020-01776-w
pii: 10.1007/s00508-020-01776-w
pmc: PMC7722244
doi:
Substances chimiques
Glucocorticoids
0
Immunoglobulin G
0
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
412-413Références
Mehta P, McAuley DF, Brown M, Sanchez E, Tatersall RS, Manson JJ, et al. COVID-19: consider cytokine storm syndromes and immunosuppression. Lancet. 2020;395(10229):1033–4. https://doi.org/10.1016/S0140-6736(20)30628-0 .
doi: 10.1016/S0140-6736(20)30628-0
Ritchie AI, Singanayagam A. Immunosuppression for hyperinflammation in COVID-19: a double-edged sword? Lancet. 2020;395(10230):1111. https://doi.org/10.1016/S0140-6736(20)30691-7 .
doi: 10.1016/S0140-6736(20)30691-7
Thomas BJ, Porritt RA, Hertzog PJ, Bardin PG, Tate MD. Glucocorticosteroids enhance replication of respiratory viruses: effect of adjuvant interferon. Sci Rep. 2014;4:7176. https://doi.org/10.1038/srep07176 .
doi: 10.1038/srep07176
Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. 2020; https://doi.org/10.1007/s00134-020-06028-z .
doi: 10.1007/s00134-020-06028-z
pubmed: 32253449
pmcid: 7131986
Guillen E, Pineiro GJ, Revuelta I, Rodriguez D, Bodro M, Moreno A, et al. Case report of COVID-19 in a kidney transplant recipient: Does immunosuppression alter the clinical presentation? Am J Transplant. 2020;20(7):1875–1878. https://doi.org/10.1111/ajt.15874 .
doi: 10.1111/ajt.15874
pubmed: 32198834